Two new studies suggest that low-density lipoprotein cholesterol (LDL-C) may be not the main driver of atherosclerotic cardiovascular disease (ASCVD). The findings instead implicate remnant ...
Expert Rev Cardiovasc Ther. 2008;6(3):391-409. Phosphatidic acid phosphatase/phosphohydrolase (PAP) is an enzyme that catalyzes the conversion of phosphatidic acid to ...
Advanced lipoprotein profiling among individuals with low LDL cholesterol levels suggests that triglyceride-rich remnant particles, specifically small very low-density lipoprotein (VLDL) particles, ...
In honor of September being National Cholesterol Education Month, Johns Hopkins is highlighting several resources available to university employees to prevent and control high cholesterol. The article ...
Two laboratory machines have played a role in perhaps the greatest medical misadventure of our time: the indictment of a villain — LDL cholesterol — with the ultimate crime of the heart, coronary ...
The third guidelines from the of the National Cholesterol Education Program’s (NCEP) Adult Treatment Panel (ATP III) have always placed an emphasis on therapeutic lifestyle changes (TLC) as an ...
Please provide your email address to receive an email when new articles are posted on . Patients with hyperlipidemia treated with evolocumab had a greater reduction in atherogenic lipoprotein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results